A groundbreaking and highly controversial scientific initiative is now underway in the UK, as leading British researchers aim ...

Investors interested in the Genomics and Synthetic Biology theme should consider these stocks: Twist Bioscience Corporation, Wave Life Sciences, and CRISPR Therapeutics AG.

DUBLIN and SAN DIEGO, March 27, 2025 /PRNewswire/ -- ERS Genomics Limited ('ERS'), the CRISPR licensing company, and Jumpcode Genomics ('Jumpcode'), a life science tools company improving and reducing ...

By application, the synthetic biology segment accounted for the highest revenue-grossing segment in the global enzymatic DNA synthesis market in 2024 owing to the increasing applications of ...

In its first special issue on Biosafety and Biosecurity Considerations of Synthetic Genomics, the first part of a two-part special issue of the peer-reviewed journal Applied Biosafety focuses on ...

INDIANAPOLIS – (April 30, 2024) – Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, has entered a collaborative partnership with Watchmaker Genomics, an ...

The aim of the Center for Synthetic Genomics is to spark new developments in synthetic genomics through basic research and technology development using methods of artificial intelligence.